Neuroprotective agents for clinical trials in Parkinson's disease A systematic assessment -
BM Ravina, SC Fagan, RG Hart, CA Hovinga, DD … - Neurology, 2003 - AAN Enterprises
... Interventions that can slow or halt the progression ... the primary aim of slowing disease
progression in ... for testing in upcoming National Institute of Neurologic ...
Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, … -
RJ Desnick, R Brady, J Barranger, AJ Collins, DP … - Annals of Internal Medicine, 2003 - annals.highwire.org
... goal is to both halt disease progression and ... Lysosomal Storage Disease Network Web
site: http ... National Institute of Neurological Disorders and Stroke National ...
[PDF] … of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease -
JD Harper, SS Wong, CM Lieber, PT Lansbury Jr - Biochemistry, 1999 - doe-mbi.ucla.edu
... too late a stage could accelerate disease by causing ... the pathogenic species to either
halt further aggregation ... CML and PTL from the National Institute on Aging ...
-
NEWS: Is Apoptosis Key in Alzheimer's Disease? -
M Barinaga - Science, 1998 - sciencemag.org
... from Luciano D'Adamio and his colleagues at the National Institute of Allergy ... doubt
that blocking it will slow or halt the progress of the disease. ...
Clinical Features of and Recent Advances in Therapy for Fabry Disease -
RO Brady, R Schiffmann - JAMA, 2000 - Am Med Assoc
... disease is expected to halt the deterioration ... showed promise in patients with Gaucher
disease. ... Metabolic Neurology Branch, National Institute of Neurological ...
Hepatitis C: The clinical spectrum of disease -
JH Hoofnagle - Hepatology, 1997 - doi.wiley.com
... of Digestive Diseases and Nutrition, National Institute of Diabetes ... MD, Bldg 31,
Room 9A23, National Institutes of ... one can halt the progression of stage, or in ...
[BOOK] The Atlas of Heart Disease and Stroke -
J Mackay, GA Mensah - 2004 - books.google.com
... Thanks to our colleagues at the National Center for ... Smoking and Health, Centers for
Disease Control and ... for Community Medicine, All India Institute of Medical ...
[PDF] MRI of the hippocampus in Alzheimer?s disease: sensitivity, specificity, and analysis of the … -
MP Laakso, H Soininen, K Partanen, M Lehtovirta, M … - Neurobiol Aging, 1998 - uku.fi
... When novel pharmaceuticals to halt the progression of AD ... very earliest stages of
the disease (5,24 ... 38), 43 subjects fulfilling the National Institute of Mental ...
-
… of disease severity on outcome of antiviral therapy for chronic hepatitis C: lessons from the HALT- … -
GT Everson, JC Hoefs, LB Seeff, HL Bonkovsky, D … - Hepatology, 2006 - doi.wiley.com
... Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and
Kidney Diseases, National Institutes of ... The HALT-C Trial is being conducted ...
Peginterferon Alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior … -
ML Shiffman, AM Di Bisceglie, KL Lindsay, C … - Gastroenterology, 2004 - Elsevier
... Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of ... Treatment against Cirrhosis (HALT-C) Trial was ...
Source: Google Scholar |